Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06056128
What this trial is testing

Confirmation of Accuracy of the Tool-in-lesion Technology (TiLT) of the Galaxy System With Integrated TOMO Technology

Who this might be right for
Lung CancerNodes, Lung
Noah Medical 25
Not applicableNo Longer AvailableNCT00210665
What this trial is testing

Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment

Who this might be right for
Sarcoma
Janssen Research & Development, LLC
Large-scale testing (Phase 3)Study completedNCT00146211
What this trial is testing

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

Who this might be right for
Huntington Disease
Amarin Neuroscience Ltd 300
Testing effectiveness (Phase 2)Looking for participantsNCT07059221
What this trial is testing

A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 210
Testing effectiveness (Phase 2)WithdrawnNCT04882163
What this trial is testing

Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Celgene
Large-scale testing (Phase 3)Study completedNCT03357471
What this trial is testing

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderate and Severe Active Rheumatoid ArthritisActive Psoriatic ArthritisActive Ankylosing Spondylitis+1 more
UCB Biopharma S.P.R.L. 70
Testing effectiveness (Phase 2)Looking for participantsNCT06667544
What this trial is testing

RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation

Who this might be right for
KRAS G12D Mutation
Ranok Therapeutics (Hangzhou) Co., Ltd. 152
Large-scale testing (Phase 3)Active Not RecruitingNCT04224493
What this trial is testing

Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

Who this might be right for
Relapsed/Refractory Follicular LymphomaFollicular LymphomaRefractory Follicular Lymphoma
Epizyme, Inc. 599
Large-scale testing (Phase 3)Study completedNCT01311687
What this trial is testing

A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study

Who this might be right for
Multiple Myeloma
Celgene 455
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Testing effectiveness (Phase 2)Study completedNCT01926444
What this trial is testing

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Who this might be right for
PainCancerColonic Diseases
gicare Pharma Inc. 308
Testing effectiveness (Phase 2)Study completedNCT01980654
What this trial is testing

Study of Ibrutinib in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma

Who this might be right for
Follicular LymphomaB-cell LymphomaNon-Hodgkin's Lymphoma
Pharmacyclics LLC. 80
Early research (Phase 1)Study completedNCT00877253
What this trial is testing

Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Samyang Biopharmaceuticals Corporation 18
Testing effectiveness (Phase 2)UnknownNCT03883802
What this trial is testing

Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer

Who this might be right for
Colon Cancer
WntResearch AB 100
Large-scale testing (Phase 3)Study completedNCT01539083
What this trial is testing

Velcade (Bortezomib) Consolidation After Transplant

Who this might be right for
Multiple Myeloma
Janssen Scientific Affairs, LLC 256
Early research (Phase 1)Study completedNCT02337205
What this trial is testing

Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis

Who this might be right for
Actinic Keratosis
Athenex, Inc. 29
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Early research (Phase 1)Study completedNCT05162469
What this trial is testing

SHR-A1909 in Subjects With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 12
Early research (Phase 1)Ended earlyNCT02346370
What this trial is testing

A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Halozyme Therapeutics 16
Large-scale testing (Phase 3)Study completedNCT02541383
What this trial is testing

Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Intergroupe Francophone du Myelome 1,085
Next Page